medigraphic.com
ISSN 0210-5187 (Electronic)

2017, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2017; 45 (1)

High-risk cutaneous squamous cell carcinoma: definition, diagnosis and management

Uribe-Bojanini E, Londoño GÁM, Jiménez CG, Sanabria QÁE, Mejía MME

Language: Spanish
References: 46
Page: 8-13
PDF size: 297.63 Kb.


ABSTRACT

Squamous cell carcinoma is the second most common cancer of the skin; some of these tumors have an aggressive behavior and can lead to metastasis and local recurrences. The carcinomas with this behavior have been termed «high-risk», but the definition and criteria are not well established and there is no consensus in the different guidelines worldwide. When a high-risk tumor is diagnosed, an aggressive approach and treatment are required, seeking higher rates of complete remission and less recurrences. This review seeks to standardize the different definitions of «high-risk» and actualize concepts about the correct diagnostic approach and treatment in this type of tumors.


REFERENCES

  1. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001; 344: 975-983.

  2. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013; 68: 957-966.

  3. Cormane J, Rodelo A. Epidemiologia del cancer no melanoma en Colombia. Rev Asoc Colomb Dermatol. 2014; 22: 20-26.

  4. Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol. 2008; 58: S129-132.

  5. Sánchez G, Nova J. Risk factors for squamous cell carcinoma, a study by the National Dermatology Centre of Colombia. Actas Dermosifiliogr. 2013; 104: 672-678.

  6. Green AC, McBride P. Squamous cell carcinoma of the skin (non-metastatic). BMJ Clin Evid. 2010; 2010.

  7. Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012; 106: 811-815.

  8. Chu MB, Slutsky JB, Dhandha MM, Beal BT, Armbrecht ES, Walker RJ et al. Evaluation of the definitions of “high-risk” cutaneous squamous cell carcinoma using the American Joint Committee on cancer staging criteria and national comprehensive cancer network guidelines. J Skin Cancer. 2014; 2014: 154340.

  9. Zwald F. Practice gaps. Toward a better definition of high-risk cutaneous squamous cell carcinoma: comment on “Factors predictive of recurrence and death from cutaneous squamous cell carcinoma”. JAMA Dermatology. 2013; 149: 547-548.

  10. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992; 26: 976-990.

  11. Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006; 106: 2389-2396.

  12. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006; 32: 1309-1321.

  13. Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006; 13: 902-909.

  14. Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatology. 2013; 149: 35-41.

  15. Ross AS, Whalen FM, Elenitsas R, Xu X, Troxel AB, Schmults CD. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg. 2009; 35: 1859-1866.

  16. Brantsch KD, Meisner C, Schönfisch B, Trilling B, Wehner-Caroli J, Röcken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008; 9: 713-720.

  17. Garcia C, Crowson AN. Acantholytic squamous cell carcinoma: is it really a more-aggressive tumor? Dermatol Surg. 2011; 37: 353-356.

  18. DeSimone J, Karia PS, Schmults CD. Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma. [Internet]. Up to Date2015; Available from: http://www.uptodate.com/contents/recognition-and-management-of-high-risk-aggressive-cutaneous-squamous-cell-carcinoma

  19. Ch’ng S, Low I, Ng D, Brasch H, Sullivan M, Davis P et al. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol. 2008; 39: 344-349.

  20. Corbalán-Vélez R, Oviedo-Ramírez I, Ruiz-Maciá JA, Conesa-Zamora P, Sánchez-Hernández M, Martínez-Barba E et al. Tinción inmunohistoquímica p16 en carcinomas epidermoides del área genital y extragenital. Actas Dermosifiliogr. 2011; 102: 439-447.

  21. Salgado R, Toll A, Alameda F, Baró T, Martín-Ezquerra G, Sanmartín O et al. CKS1B amplification is a frequent event in cutaneous squamous cell carcinoma with aggressive clinical behaviour. Genes Chromosomes Cancer. 2010; 49: 1054-1061.

  22. Glazer ES, Bartels PH, Prasad AR, Yozwiak ML, Bartels HG, Einspahr JG, et al. Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma. Cancer Prev Res (Phila). 2011; 4: 1770-1777.

  23. Warner CL, Cockerell CJ. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol. 2011; 12: 147-154.

  24. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, Hwang WT, Gelfand JM, Whalen FM, et al. Evaluation of AJCC Tumor Staging for Cutaneous Squamous Cell Carcinoma and a Proposed Alternative Tumor Staging System. JAMA Dermatology. 2013; 149: 402.

  25. Schmitt AR, Brewer JD, Bordeaux JS, Baum CL. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. JAMA Dermatology. 2014; 150: 19-24.

  26. Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol. 2010; 3: 39-48.

  27. Vidimos AT, Stulz T. Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma. [Internet]. Up to Date2015; Available from: http://www.uptodate.com/contents/evaluation-for-locoregional-and-distant-metastases-in-cutaneous-squamous-cell-and-basal-cell-carcinoma

  28. Anzai Y, Brunberg JA, Lufkin RB. Imaging of nodal metastases in the head and neck. J Magn Reson Imaging. 1997; 7: 774-783.

  29. Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys. 2001; 49: 1061-1069.

  30. Ginsberg LE. MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am. 2002; 10: 511-525, vi.

  31. Alam M. Uncertainty and variance in the management of high-risk cutaneous squamous cell carcinoma: comment on “Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons”. Arch Dermatol. 2010; 146: 1231-1232.

  32. Knappe M, Louw M, Gregor RT. Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases. Arch Otolaryngol Head Neck Surg. 2000; 126: 1091-1096.

  33. Colciencias, MinSalud. Guía Colombiana de Práctica Clínica: Carcinoma escamocelular de piel. 2014; 1-112.

  34. Stratigos A, Garbe C, Lebbe C, Malvehy J, Del Marmol V, Pehamberger H, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015; 51: 1989-2007.

  35. Renzi C, Caggiati A, Mannooranparampil TJ, Passarelli F, Tartaglione G, Pennasilico GM et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol. 2007; 33: 364-369.

  36. Navarrete-Dechent C, Veness MJ, Droppelmann N, Uribe P. High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review. J Am Acad Dermatol. 2015; 73: 127-137.

  37. Takahashi A, Imafuku S, Nakayama J, Nakaura J, Ito K, Shibayama Y. Sentinel node biopsy for high-risk cutaneous squamous cell carcinoma. Eur J Surg Oncol. 2014; 40: 1256-1262.

  38. Allen JE, Stolle LB. Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. Eur J Surg Oncol. 2015; 41: 197-200.

  39. Gore SM, Shaw D, Martin RC, Kelder W, Roth K, Uren R et al. Prospective study of sentinel node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2016; 38 (Suppl 1): E884-889.

  40. Krediet JT, Beyer M, Lenz K, Ulrich C, Lange-Asschenfeldt B, Stockfleth E et al. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol. 2015; 172: 1029-1036.

  41. Mateus C. Cutaneous squamous cell carcinoma. Rev Prat. 2014; 64: 45-52.

  42. Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013; 347: f6153.

  43. Jambusaria-Pahlajani A, Miller CJ, Quon H, Smith N, Klein RQ, Schmults CD. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg. 2009; 35: 574-585.

  44. Bichakjian K, Olencki T. NCCN Guidelines Version 1.2016 updates squamous cell skin cancer. Natl Compr Cancer Netw. 2016; 1-41.

  45. Martorell-Calatayud A, Sanmartín Jimenez O, Cruz Mojarrieta J, Guillén Barona C. Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr. 2013; 104: 367-379.

  46. Akhter M, Hossain S, Rahman QB, Molla MR. A study on histological grading of oral squamous cell carcinoma and its co-relationship with regional metastasis. J Oral Maxillofac Pathol. 2011; 15: 168-176.




2020     |     www.medigraphic.com